SynthesisExpert opinion on investigational drugs2016

Clinical outcome of treatment with serine-threonine kinase inhibitors in recurrent epithelial ovarian cancer: a systematic review of literature.

Marcia A Ciccone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.